<![CDATA[3 Things You Should Know About Translating ctDNA Into Clinical Decisions in Breast Cancer]]>
LEARNING OBJECTIVES Upon successful completion of this activity, you should be better prepared to: • Interpret ctDNA and molecular residual disease data from clinical trials to inform patient-centered decision-making in early-stage and metastatic breast …